Stadiul cunoaşterii.... - Gr.T. Popa

More documents

Recommendations

Info

Corelaţii clinice,imunohistochimice şi morfopatologice în unele tumori de ovar Coordonator ştiinţific:Prof.Dr.Zenovia Florentina Pricop __________________________________________________Doctorand:Ioana Buda 75. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA 1996; 65:5-27. 76. Parker, D., Bradley, C., Bogle, S. M., Lay, J., Masood, M., Hancock, A. K. et al. (1994). Serum albumin and CA125 are powerful predictors of survival in epithelial ovarian cancer. Br. J. Obstet. Gynaecol. 101(10), 888– 893. 77. Pautier P, Lhomme C, Culine S, et al. Adult granulosa cell tumor of the ovary: a retrospective study of 45 cases. Int J Gynecol Cancer 1997;7:58–65 78. Pearl, M. L., Yashar, C. M., Johnston, C. M., Reynolds, R. K., and Roberts, J. A. (1994). Exponential regression of CA 125 during salvage treatment of ovarian cancer with taxol. Gynecol. Oncol. 53(3), 339–343. 79. Powell JL, Otis CN. Management of advanced juvenile granulosa cell tumor of the ovary. Gynecol Oncol. Feb 1997;64(2):282-4. 80. Prat J., Matias-Guiu X., Barreto J., Simultaneous carcinoma involving the endometrium and the ovary: a clinicopathologic, immunohistochemical, and DNA flow cytometric study of 18 cases, Cancer, 1991, 68: 2455- 2459 81. Pricop M., Oncologie ginecologică clinică, Editura Polirom, Iaşi, 2000 82. Pricop M.,Chirurgie ginecologica.Puncte de vedere,Institutul European,2006 125-133 83. Pricop M.Curs de obstetrica si ginecologie ,Institutul European 2001,Volumul 2-Ginecologia 267-296 84. Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T, et al. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 1995;55:4575–80. 85. Rubin SC, Sabbatini P, Randall ME. Ovarian Cancer. In: Pazdur R, Hoskins WH, Wagman L, eds. Cancer Management: A Multidisciplinary Approach. 4th ed. Mellville, NY: PRR Incorporated; 2000:. 409-28. 86. Sadler T.W,Embriologie medicala,Callisto ,2007 87. Sakaki M, Hirokawa M, Horiguchi H, Wakatsuki S, Sano T, Izumi Y: Ovarian fibrothecoma with massive edema. J Med Invest 2000, 47:148-150 88. Skirnisdóttir I, Seidal T, Gerdin E, sorbe B – The prognostic importance of p53, Bcl-2, and Bax in early stage epithelial ovarian carcinoma treated with adjuvant chemotHERapy, Int J Gynecol Cancer, 2002, 12(3):265-276 89. Slamon D J. Godolphin W, Jones LA el al. Studies of the HER-2, neu proto-oncogene in human breast and ovarian cancer. Science 1989: 244:707 712 90. Slotman BJ & Rao BR 1988 Ovarian cancer (review): etiology, diagnosis, prognosis, surgery, radiotHERapy, chemotHERapy and endocrine tHERapy. Anticancer Research 8 417–434. Endocrine-Related Cancer (2000) 7 85–93 91. Surcel I.V.-Obstetrica si ginecologie,Dacia ,2005,925-939 92. Vang R, Gown AM, Barry TS, Wheeler DT, Ronnett BM, 2006b. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 174 cases. Am J Surg Pathol. 30(9):1130-1139).- 93. Vermorken JB, Parmar MKB, Brady MF – Clinical trials in ovarian carcinoma: study methodology, Ann Oncol, 2005;16:20-29 94. Yamamoto S, Konishi I, Mandai M, Kuroda H, Komatsu T, Nanbu K, et al. Expression of the vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasm: correlation with clinicopathology and patients survival, and analysis of serum VEGF levels. Br J Cancer 1997;76:1221–7. 80
Corelaţii clinice,imunohistochimice şi morfopatologice în unele tumori de ovar Coordonator ştiinţific:Prof.Dr.Zenovia Florentina Pricop __________________________________________________Doctorand:Ioana Buda 95. Young RH, Dickersin GR, Scully RE. Juvenile granulosa cell tumor of the ovary. A clinicopathological analysis of 125 cases. Am J Surg Pathol. Aug 1984;8(8):575-96. 96. Zanetta G, Rota S, Chiari S, Bonazzi C, Bratina G, Mangioni C. Behavior of LMPtumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol. 19(10): 2658-64, May 2001. 97. Zanoschi Ch.,Tratat de anatomie ginecologica,Scripta Manent 2004 81
Page 1 and 2:
Corelaţii clinice,imunohistochimic
Page 3 and 4:
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30: Corelaţii clinice,imunohistochimic
Page 79: Corelaţii clinice,imunohistochimic
show all

Stadiul cunoaşterii.... - Gr.T. Popa

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?